The origins of BIOHYALUX are closely connected to Bloomage Biotech, which was founded in 2000 and initially built its business around the industrial production of hyaluronic acid through microbial fermentation. Bloomage states it became the world’s largest HA producer in 2007 and subsequently expanded its research into areas including glycobiology, cell biology, tissue regeneration, and aging intervention.[1]

The BIOHYALUX name first appeared prominently in the medical-aesthetic field. According to Bloomage’s corporate history, its first domestically produced cross-linked hyaluronic-acid dermal filler, BIOHYALUX, received Chinese market approval in 2012.[1]

The name later developed into a consumer-facing skincare brand. Bloomage describes BIOHYALUX as one of its core strategic brands, originating from its medical-aesthetic experience and its long-term research into hyaluronic acid and the extracellular matrix (ECM).[1] This history is significant because BIOHYALUX is not simply a conventional cosmetics brand that uses hyaluronic acid; its identity is built around Bloomage’s broader HA research and manufacturing expertise.

Bloomage Biotech is the parent company behind BIOHYALUX. Founded in 2000, it operates across biological materials, pharmaceuticals, medical aesthetics, nutrition, and skincare. Its technology platform has historically centered on hyaluronic acid but has expanded into other bioactive substances and cellular research.[1]

Bloomage describes BIOHYALUX as part of its portfolio of consumer and beauty brands, alongside brands such as QUADHA, MedRepair, and Bio-MESO.[1] The parent company states its HA materials have more than 200 specifications and are used across pharmaceutical, medical-device, cosmetics, and nutrition applications. It also notes that its materials business serves more than 4,000 brands across over 70 countries and regions.

It is important to distinguish between the two entities: Bloomage Biotech is the biotechnology and manufacturing company, while BIOHYALUX is one of its consumer-facing brands.

BIOHYALUX positions itself around the concept that healthy-looking skin depends not only on surface hydration but also on the condition of the skin’s underlying biological environment.

Its original skincare positioning emphasized hyaluronic acid at multiple molecular weights, allowing the brand to formulate products intended to address different aspects of hydration and skin conditioning. More recently, Bloomage has positioned BIOHYALUX around cellular repair and the extracellular matrix, utilizing its proprietary INFIHA Total Cellular Repair Technology.[1]

The brand’s evolution can be summarized as follows:

Hyaluronic acid → multi-molecular HA → skin repair → extracellular matrix/cellular science

One of BIOHYALUX’s best-known earlier skincare technologies is HHAF, or Hexagonal Hyaluronic Acid Formulation.

This concept involves combining different molecular-weight forms of hyaluronic acid rather than relying on a single HA molecular size. BIOHYALUX describes four components:[2]

• High-molecular-weight HA
• Medium-molecular-weight HA
• miniHA®
• microHA™

According to the brand, the different molecular sizes are intended to perform distinct roles within the skincare formulation: larger molecules primarily support surface protection and moisture retention, while smaller forms are designed to provide deeper hydration.[2] This multi-molecular approach became one of BIOHYALUX’s major points of differentiation in the skincare market.

BIOHYALUX’s current corporate positioning has moved beyond HHAF toward INFIHA Total Cellular Repair Technology.

Bloomage describes INFIHA as a technology developed from its research in cell biology, glycobiology, and regenerative medicine. The concept focuses on the extracellular matrix (ECM)—the biological environment surrounding cells—and its relationship with skin condition.[1]

According to Bloomage, the technology combines three concepts:

1. HA targeted-recognition technology — intended to help deliver active components to relevant skin and cellular environments.
2. miRNA-related cellular mechanisms — intended to support cellular self-repair pathways.
3. A cell-nutrient formulation — intended to optimize the surrounding cellular environment and support cell activity.[1]

These represent the company’s technological and marketing claims rather than a blanket clinical conclusion that all BIOHYALUX products repair skin cells. Individual products should be evaluated according to their ingredients, formulation, regulatory status, and clinical evidence.

The BIOHYALUX skincare range has expanded substantially beyond its original ampoule concept. Current product listings in markets such as Vietnam include products aimed at:[2]

• Intensive hydration
• Skin soothing and recovery
• Skin-barrier support
• Brightening
• Oil control
• Firming
• Anti-oxidative care
• Masks and specialized treatments

Examples include HA Hydro Intense Serum, HA Soothing Recovery Serum, HA Brightening & Boosting Serum, HA Lifting & Firming Serum, HA Purifying Serum, and HA Antioxidant Renewal Serum.[2] The international retail assortment also includes HA toners, emulsions, masks, and single-use essence and ampoule products.[3]

Single-use ampoules

One of the formats most strongly associated with BIOHYALUX is its single-use essence/ampoule. The brand has used BFS (Blow-Fill-Seal) packaging technology for certain small-format HA essence products. BFS is an integrated manufacturing process in which a container is formed, filled, and sealed within the production line. Bloomage has described this technology as part of its approach to small-package hyaluronic-acid essence products.

This format gives BIOHYALUX a distinctive identity compared with conventional pump bottles and dropper serums.

BIOHYALUX should not be confused exclusively with skincare, as the brand also has a significant dermal-filler heritage. Bloomage’s corporate history identifies BIOHYALUX as its first domestically produced cross-linked HA dermal filler, approved in China in 2012.[1]

There is published clinical literature specifically concerning BioHyalux hyaluronic-acid filler. A randomized, double-blind, controlled clinical trial involving 88 subjects compared BioHyalux with Restylane for the correction of nasolabial folds. The study reported that BioHyalux was non-inferior to Restylane at six months under the study’s predefined outcome and reported predominantly mild-to-moderate, transient adverse events.[4]

This distinction is essential for understanding the brand ecosystem: BioHyalux skincare and BioHyalux injectable fillers are related through the Bloomage/BIOHYALUX brand but are not the same type of product.

BIOHYALUX occupies a unique position between cosmetics, dermocosmetics, biotechnology, and medical aesthetics. Its competitive identity is built around several elements:

1. Hyaluronic-acid expertise: The brand draws on Bloomage’s decades of experience in HA production and research.[1]
2. Medical-aesthetic heritage: The brand originated partly from Bloomage’s experience with HA-based injectable products.[1]
3. Biotechnology positioning: Rather than presenting itself simply as a moisturizing skincare brand, BIOHYALUX emphasizes molecular science, ECM biology, and cellular mechanisms.[1]
4. Multi-level hydration: HHAF provided the brand with an identifiable technical story based on different molecular-weight HA components.[2]
5. Repair-oriented skincare: The brand increasingly emphasizes skin recovery, barrier support, and cellular/ECM health rather than hydration alone.[1]

The development of BIOHYALUX can be broadly understood in three stages:

1. Medical-aesthetic stage

The BIOHYALUX name was initially associated with Bloomage’s HA dermal-filler business, with a major milestone being Chinese approval in 2012.[1]

2. HA skincare stage

The brand expanded into consumer skincare and developed its HHAF multi-molecular-weight HA concept, launching products such as single-use ampoules and HA-focused essences.[2]

3. Cellular-repair stage

Bloomage’s more recent positioning moves BIOHYALUX toward ECM and cellular science, represented by the INFIHA Total Cellular Repair Technology.[1]

BIOHYALUX has been marketed outside mainland China, including throughout Asian beauty markets. It has dedicated market and distribution activity in countries such as Vietnam and Thailand, while international retailers also list the brand’s skincare products.[2]

In Thailand, the brand is particularly visible in the aesthetic-medicine sector due to its association with hyaluronic-acid fillers, although its skincare identity is also present in the broader beauty market. Current Thai medical-aesthetic sources describe Biohyalux as a Chinese HA filler brand and discuss its different filler models.[5]

BIOHYALUX is best understood as a Bloomage Biotech beauty brand that translates the company’s long-standing expertise in hyaluronic acid and medical aesthetics into consumer skincare, increasingly using extracellular-matrix and cellular-biology concepts as its scientific positioning.

Its differentiation is not merely the use of hyaluronic acid, which is common in the industry. Instead, BIOHYALUX attempts to connect HA science, molecular-weight technology, medical aesthetics, biotechnology, and skin-repair research into a unified brand identity.

Some descriptions of BIOHYALUX use phrases such as “cellular repair,” “deep penetration,” “regeneration,” or “activating cells.” These should be interpreted as brand technology and marketing descriptions, not as proof that every product produces a medically demonstrated cellular-repair effect.

For a rigorous evaluation, it is advisable to separate:

• Bloomage’s underlying HA and biotechnology research
• The patented or proprietary technology used in a particular product
• The ingredients and concentrations of that product
• Clinical studies on that specific formulation
• Cosmetic claims made by the brand

This distinction is especially important because BIOHYALUX spans both cosmetic skincare and medical-aesthetic products.

1. BIOHYALUX
2. CÔNG NGHỆ HHAF và HHAF+ KHÁC NHAU NHƯ THẾ NÀO? – Biohyalux Vietnam
3. BIOHYALUX | YesStyle
4. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds in Chinese subjects: BioHyalux versus Restylane – PubMed
5. รู้จักฟิลเลอร์ Biohyalux สัญชาติจีน ดีอย่างไร ? ทำไมแพทย์ถึงเลือกใช้